Key points from article :
Celularity is a spinout from Celgene, a global biopharmaceutical company.
Hopes to use stem cells from placenta to regenerate tissue and organs.
Several clinical trials conducted - next step is FDA approval.
Approximately four million human placentas are disposed of per year in U.S. hospitals.
"Our ultimate mission is to make 100 years old the new 60" - Peter Diamandis.
